awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46106006-6622C2A8-09BA-43BD-AB25-4D4787CE87FD
Q46106006-6622C2A8-09BA-43BD-AB25-4D4787CE87FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46106006-6622C2A8-09BA-43BD-AB25-4D4787CE87FD
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.
P2860
Q46106006-6622C2A8-09BA-43BD-AB25-4D4787CE87FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46106006-6622C2A8-09BA-43BD-AB25-4D4787CE87FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16bd4de638df98616fff0324a84f0c0f2dc980ee
P2860
Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.